Insider Trading Summary for Dyne Therapeutics, Inc. (DYN): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
28-Feb-24 7:13 PM View:	28-Feb-24 Sale (Planned) ($900.23K)	Atlas Venture Fund Xi, L.P. 10% Owner		Dyne Therapeutics, Inc. - DYN	10% 7.33M to 8.05M	0	0	--	--	Show Txns Hide Txns

19-Sep-24 4:52 PM View:	18-Sep-24 Private Sale (Planned) ($308.86K)	High Susanna Gatti Chief Operating Officer		Dyne Therapeutics, Inc. - DYN	(31%) 189.5K to 131.64K	0	($17.32K) (1%)	--	$10.72	Show Txns Hide Txns

18-Nov-24 5:31 PM View:	14-Nov-24 Private Sale ($25.88K)	Rhodes Jason P Director		Dyne Therapeutics, Inc. - DYN	(19%) 9.87M to 8.02M	0	0	--	--	Show Txns Hide Txns

20-Aug-24 4:27 PM View:	19-Aug-24 Private Sale (Planned) ($104.73K)	Farwell Wildon Chief Medical Officer		Dyne Therapeutics, Inc. - DYN	(17%) 171.76K to 143.22K	0	($28.41K) (2%)	--	$10.55 - $10.72	Show Txns Hide Txns

18-Nov-24 10:00 PM View:	18-Nov-24 Private Sale (Planned) ($80.54K)	Beskrovnaya Oxana Chief Scientific Officer		Dyne Therapeutics, Inc. - DYN	(23%) 178.05K to 137.52K	0	($15.73K) (1%)	--	$10.72	Show Txns Hide Txns

18-Nov-24 7:42 PM View:	18-Nov-24 Option Sale ($474.04K)	Incerti Carlo Director		Dyne Therapeutics, Inc. - DYN	0% --	0	0	--	--	Show Txns Hide Txns

20-Aug-24 4:27 PM View:	19-Aug-24 Private Sale (Planned) ($122.05K)	McNeill Jonathan Chief Business Officer		Dyne Therapeutics, Inc. - DYN	(16%) 156.76K to 132.11K	0	($13.35K) (1%)	--	$10.72	Show Txns Hide Txns

19-Sep-24 4:52 PM View:	18-Sep-24 Private Sale (Planned) ($48.02K)	Scalzo Richard William SVP, Head of Finance & Admin.		Dyne Therapeutics, Inc. - DYN	(24%) 130.54K to 98.57K	0	($14.79K) (1%)	--	$10.72	Show Txns Hide Txns

12-Mar-24 9:56 PM View:	11-Mar-24 Sale (Planned) ($202.93K)	Brumm Joshua T CEO & President Director		Dyne Therapeutics, Inc. - DYN	(9%) 592.56K to 538.0K	0	($81.31K) (1%)	--	$10.72	Show Txns Hide Txns

05-Mar-24 5:07 PM View:	01-Mar-24 Sale (Planned) ($513.82K)	Atlas Venture Opportunity F... 10% Owner		Dyne Therapeutics, Inc. - DYN	(2%) 2.35M to 2.31M	0	0	--	--	Show Txns Hide Txns

15-Nov-24 4:05 PM View:	14-Nov-24 Sale ($293.05K)	Kersten Dirk Director		Dyne Therapeutics, Inc. - DYN	(5%) 6.13M to 5.85M	0	0	--	--	Show Txns Hide Txns

03-Sep-24 6:16 PM View:	03-Sep-24 Grant 0	Friedl-Naderer Johanna Chief Commercial Officer		Dyne Therapeutics, Inc. - DYN	100% 0 to 58.4K	0	0	--	--	Show Txns Hide Txns

03-Sep-24 6:22 PM View:	03-Sep-24 Grant 0	Kerr Douglas Chief Medical Officer		Dyne Therapeutics, Inc. - DYN	100% 0 to 47.5K	0	0	--	--	Show Txns Hide Txns

04-Sep-24 5:42 PM View:	04-Sep-24 Purchase $1.06M	Cox John CEO & President Director		Dyne Therapeutics, Inc. - DYN	640% 5.0K to 37.0K	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	($170.91K)	$10.55 - $10.72

Dyne Therapeutics, Inc. (DYN)

Last Year

25-Nov-23 -- 24-Nov-24

Company Sentiment

Other

Other

Two Year Chart

25-Nov-22 -- 24-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades